Sun Pharma Q2 net plunges 59% at Rs 912 cr

Analysts on average had expected a profit of Rs 827 crore, according to Thomson Reuters data

A logo of Sun Pharmaceutical Industries Ltd is pictured at its research and development centre in Mumbai (Photo: Reuters)

1 min read Last Updated : Nov 14 2017 | 5:02 PM IST

India's largest drugmaker, Sun Pharmaceutical Industries Ltd, posted a 59 per cent plunge in second-quarter profit on Tuesday, but beat estimates.

Profit came in at Rs 912 crore ($139.48 million) in the quarter ended Sept. 30, compared with Rs 2,235 crore a year ago, the company said.

Analysts on average had expected a profit of Rs 827 crore, according to Thomson Reuters data.

First Published: Nov 14 2017 | 4:58 PM IST